IgG1-κ biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism

British Journal of Haematology

Volumn 102, Issue 2, 1998, Pages 503-508

  Pizzolato, M ^a   Bragantini, G ^a   Bresciani, P ^a   Pavlovsky, S ^a   Chuba, J ^b   Vidal, R ^b   Rostagno, A ^b   Ghiso, J ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biclonal gammopathy; Clonal regulation; Melphalan; Myeloma; Prednisone

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G1; MELPHALAN; PREDNISONE;

AGED; ARTICLE; CASE REPORT; CELL CLONE; DISEASE ASSOCIATION; GAMMOPATHY; HUMAN; MALE; MALIGNANT TRANSFORMATION; MULTIPLE MYELOMA; MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENCE JONES PROTEIN; FATAL OUTCOME; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-ALPHA; MALE; MELPHALAN; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PARAPROTEINS; PREDNISONE; SEQUENCE ANALYSIS;

EID: 0031871163     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00805.x     Document Type: Article

References (15)

1. Boccadoro, M. & Pileri, A. (1997) Diagnosis, prognosis, and standard treatment of multiple myeloma. Heamotogy/Oncology Clinics of North America, 11, 111-125.
2. Fair, D.S., Siedge, C., Krueger, R.G., Mann, K.G. & Hood, L.E. (1975) Studies on IgA and IgG monoclonal proteins derived from a single patient: evidence for identical light chains and variable regions of the heavy chain. Biochemistry, 14, 5561-5568.
3. Goñi, F., Chuba, J., Buxbaum, J. & Frangione, B. (1988) A double monoclonal IgG1k and IgG2k in a single myeloma patient: variation in clonal products and therapeutic responses. Journal of Immunology, 140, 551-557.
4. Goranov, S. (1994) Clinical aspects of biclonal myelomas. Folia Medica, 36, 31-36.
5. Grogan, T.M. & Spier, C.M (1992) The B cell immunoproliferative disorders, including multiple myeloma and amyloidosis. Neoplastic Hematology (ed, by D. M. Knowles). pp. 1235-1265. Williams & Wilkins, Baltimore.
6. Kozuru, M., Ulke, N., Takahira, H., Yufu, Y., Goto, T. & Muta, K. (1997) Immunoglobulin class switch from IgA1 to IgG2 and simultaneous association with Bence Jones proteinuria in the escape phase in a myeloma patient treated with interferon alpha. British Journal of Haematology, 98, 114-118.
7. Kyle, R.A. (1993) Benign monoclonal gammopathy after 20 to 35 years of follow-up. Mayo Clinic Proceedings, 68, 26-36.
8. Kyle, R.A. (1994) The monoclonal gammopathies. Clinical Chemistry, 40, 2154-2161.
9. Kyle, R.A. (1997) Monoclonal gammopathy of undetermined significance and solitary plasmocitoma: implications for progression to overt multiple myeloma. Hematology/Oncology Clinics of North America, 11, 71-87.
10. Kyle, R.A., Robinson, R.A. & Katzmann, J.A. (1981) Clinical aspects of biclonal gammopathies. American Journal of Medicine, 71, 999-1008.
11. Matsudaira, P. (1987) Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. Journal of Biological Chemistry, 262, 10035-10038.
12. Munshi, N. (1997) Immunoregulatory mechanisms in multiple myeloma. Hematology/Oncology Clinics of North America, 11, 51-69.
13. Podell, D.N. & Abraham, G.N. (1978) A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase. Biochemical and Biophysical Research Communications, 81, 176-185.
14. Wang, A.C., Gergely, J. & Fudenberg, H.H. (1973) Amino acid sequences at constant and variable regions of heavy chains of monotypic immunoglobulins G and M of a single patient. Biochemistry, 12, 528-534.
15. Wang, A.C., Wilson, S.K., Hopper, J.E., Fudenberg, H.H. & Nisonoff, A. (1970) Evidence for control of synthesis of the variable regions of the heavy chains of immunoglobulins G and M by the same gene. Proceedings of the National Academy of Sciences of the United States of America, 66, 337-343.